Ruxolitinib
Showing 1 - 25 of 327
Ruxolitinib in Patients With Myelofibrosis
Not yet recruiting
- Myelofibrosis
- Ruxolitinib
- (no location specified)
Feb 28, 2023
Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)
Approved for marketing
- Graft-versus-host Disease (GVHD)
- Ruxolitinib
- (no location specified)
Jan 26, 2023
Ruxolitinib in Patients With Myelofibrosis
Completed
- Myelofibrosis
- Ruxolitinib
- (no location specified)
Jun 5, 2022
Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)
Not yet recruiting
- Haemophagocytic Lymphohistiocytosis
- Ruxolitinib
- (no location specified)
Feb 28, 2023
Prurigo Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Feb 23, 2023
Atopic Dermatitis Trial in Culver City (Ruxolitinib cream, Vehicle)
Recruiting
- Atopic Dermatitis
- Ruxolitinib cream
- Vehicle
-
Culver City, CaliforniaScience37
Jan 12, 2023
Seborrheic Dermatitis Trial in New York (Ruxolitinib 1.5% Cream)
Recruiting
- Seborrheic Dermatitis
- Ruxolitinib 1.5% Cream
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 15, 2023
Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo Nodularis
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Mar 1, 2023
Nonsegmental Vitiligo With Genital Involvement Trial (Ruxolitinib Cream)
Not yet recruiting
- Nonsegmental Vitiligo With Genital Involvement
- Ruxolitinib Cream
- (no location specified)
Feb 20, 2023
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
- Ruxolitinib
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Atopic Dermatitis (AD) Trial (Ruxolitinib Cream)
Not yet recruiting
- Atopic Dermatitis (AD)
- Ruxolitinib Cream
- (no location specified)
Jul 8, 2022
Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)
Recruiting
- Chronic Hand Dermatitis
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
Aug 9, 2022
MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)
Recruiting
- MDS/MPN
- Azacitidine (AZA) with Ruxolitinib
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023
Myelofibrosis Trial in Jinan (Ruxolitinib)
Recruiting
- Myelofibrosis
- Ruxolitinib
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jul 3, 2022
T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)
Not yet recruiting
- T-Cell Large Granular Lymphocyte Leukemia
- Ruxolitinib
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 20, 2022
aGVHD, Stem Cell Transplant Complications Trial in Beijing (Ruxolitinib 10 mg twice a day combined with Corticosteroids,
Completed
- aGVHD
- Stem Cell Transplant Complications
- Ruxolitinib 10 mg twice a day combined with Corticosteroids
- +3 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 12, 2021
Vitiligo Trial in Nice (Ruxolitinib Topical, Placebo)
Not yet recruiting
- Vitiligo
- Ruxolitinib Topical
- Placebo
-
Nice, Alpes-maritimes, FranceCHU de Nice - Hôpital de l'Archet
May 22, 2023
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
- Fostamatinib
- Ruxolitinib
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)
Recruiting
- Colorectal Cancer
- Pancreatic Adenocarcinoma
- Trametinib
- Ruxolitinib
-
Singapore, SingaporeNational Cancer Centre
Jun 10, 2022
Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)
Recruiting
- Hematopoietic Stem Cell Transplant (HSCT)
- Bronchiolitis Obliterans (BO)
- Ruxolitinib
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 6, 2022
Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Long-term Follow-up
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)
Completed
- Necrobiosis Lipoidica
- Ruxolitinib
-
Scottsdale, ArizonaMayo Clinic in Arizona
Mar 17, 2022
Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)
Enrolling by invitation
- Discoid Lupus Erythematosus
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
May 20, 2022
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023